External validation of the Michigan PICC catheter–associated bloodstream infections score (MPC score) for predicting the risk of peripherally inserted central catheter–associated bloodstream infections: A single-center study in Japan

2021 ◽  
pp. 1-4
Author(s):  
Hirotaka Sakai ◽  
Mitsunaga Iwata ◽  
Teruhiko Terasawa
Keyword(s):  
External Validation ◽  
Bloodstream Infections ◽  
University Hospital ◽  
Case Mix ◽  
Peripherally Inserted Central Catheter ◽  
Medical Patients ◽  
Central Catheter ◽  
Single Center ◽  
Single Center Study ◽  
Center Study

Abstract The Michigan peripherally inserted central catheter–associated bloodstream infection score (MPC score) had been developed for hospitalized medical patients but had not been externally validated. A retrospective analysis of a clinically heterogeneous case-mix in a university hospital cohort in Japan failed to validate its originally reported good performance.

scholarly journals Safety and efficacy of thromboprophylaxis with fondaparinux in elderly acutely ill medical patients with renal impairment: a retrospective single center study

2013 ◽  
Vol 7 (4) ◽  
pp. 287
Author(s):  
Federico Silvestri ◽  
Samantha Pasca ◽  
Marco Zaramella ◽  
Antonella Labombarda ◽  
Andrea Barbi ◽  
...  
Keyword(s):  
Renal Impairment ◽  
Medical Patients ◽  
Single Center ◽  
Safety And Efficacy ◽  
Single Center Study ◽  
Center Study

Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohort

2014 ◽  
Vol 33 (3) ◽  
pp. 381-388 ◽  
Author(s):  
Stefan Zastrow ◽  
Sabine Brookman-May ◽  
Thi Anh Phuong Cong ◽  
Stanislaw Jurk ◽  
Immanuel von Bar ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
External Validation ◽  
Curve Analysis ◽  
Study Cohort ◽  
Single Center ◽  
Decision Curve Analysis ◽  
Single Center Study ◽  
Center Study

scholarly journals Evaluation Of Incidence Of Acute Kidney Injury Cases And Their Renal Biopsies Results In Beni-Suef University Hospital. A Single Center Study

2021 ◽  
Vol 2 (2) ◽  
pp. 43-58
Author(s):  
Heba Hamdy Mahmoud ◽  
Wesam Maghawry Ismail ◽  
Ahmed Saeed Abd Elsattar ◽  
Asmaa Kamel Sayed
Keyword(s):  
Acute Kidney Injury ◽  
Kidney Injury ◽  
University Hospital ◽  
Single Center ◽  
Single Center Study ◽  
Renal Biopsies ◽  
Center Study

scholarly journals Low prevalence of SARS‐CoV‐2 specific antibodies among endoscopists and their assistants in a university hospital in Tochigi prefecture–A single‐center study

DEN Open ◽  
2021 ◽  
Vol 2 (1) ◽  
Author(s):  
Kouichi Miura ◽  
Hiroshi Maeda ◽  
Naoshi Arai ◽  
Mariko Sekiya ◽  
Akihiro Miyano ◽  
...  
Keyword(s):  
University Hospital ◽  
Single Center ◽  
Specific Antibodies ◽  
Single Center Study ◽  
Low Prevalence ◽  
Center Study

Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study

2016 ◽  
Vol 95 (6) ◽  
pp. 871-879 ◽  
Author(s):  
Christian Kjellander ◽  
Magnus Björkholm ◽  
Owe Källman ◽  
Christian G. Giske ◽  
Caroline E. Weibull ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
Bloodstream Infections ◽  
Lymphocytic Leukemia ◽  
Single Center ◽  
Single Center Study ◽  
Center Study

scholarly journals Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study

2020 ◽  
Author(s):  
Oğuz Abdullah UYAROĞLU ◽  
Nursel Çalik BAŞARAN ◽  
Lale ÖZIŞIK ◽  
Gülçİn Tellİ DİZMAN ◽  
İmdat EROĞLU ◽  
...  
Keyword(s):  
Readmission Rate ◽  
Tertiary Care ◽  
Information Management System ◽  
University Hospital ◽  
Research Database ◽  
Single Center ◽  
Important Indicator ◽  
Moderate Severity ◽  
Single Center Study ◽  
Center Study

Abstract Background The 30-day readmission rate is an important indicator of patient safety and hospital’s quality performance. In this study, we aimed to find out the 30-day readmission rate of mild and moderate severity coronavirus disease of 2019 (COVID-19) patients discharged from a tertiary care university hospital and to demonstrate the possible factors associated with readmission. Methods This is an observational, single-center study. Epidemiological and clinical data of patients who were hospitalized with a diagnosis of COVID-19 were retrieved from a research database where patient information was recorded prospectively. Readmission data were sought from the hospital information management system and the National Health Information System to detect if the patients were readmitted to any hospital within 30 days of discharge. Adult patients (≥18 years old) hospitalized in COVID-19 wards with a diagnosis of mild or moderate COVID-19 between 20 March 2020 (when the first case was admitted to our hospital) and 26 April 2020 were included. Results From 26 March to 1 May, there were 154 mild or moderate severity (non-critical) COVID-19 patients discharged from COVID-19 wards, of which 11 (7.1%) were readmitted. The median time of readmission was 8.1 days (interquartile range [IQR] = 5.2). Two patients (18.1%) were categorized to have mild disease and the remaining 9 (81.9%) as moderate disease. Two patients who were over 65 years of age and had metastatic cancers and hypertension developed sepsis and died in the hospital during the readmission episode. Malignancy (18.7% vs. 2.1%, P = 0.04) and hypertension (45.5% vs. 14%, P = 0.02) were more common in those who were readmitted. Conclusions This is one of the first studies to report on 30-day readmission rate of COVID-19 in the literature. More comprehensive studies are needed to reveal the causes and predictors of COVID-19 readmissions.

Sign in / Sign up

Export Citation Format

Share Document